HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avon estimates

This article was originally published in The Rose Sheet

Executive Summary

Third quarter earnings are expected to be up 13%, in line with analyst predictions, while income in the fourth quarter will fall below estimates, the company announced Sept. 29. Avon is expected to rebound for the year, with earnings up double-digits, representing "very solid growth" over the company's 17% income increase in 1998, the company said. In the U.S., "trends in beauty sales in the fourth quarter are expected to improve significantly over third quarter" in light of "weakness in early sales of holiday gifts." The stock tumbled 38.3% to 25-13/16 on Sept. 29 on the news. The direct seller had earlier told analysts that fourth quarter sales will be up about 2% versus Street expectations of 3% to 4% (1"The Rose Sheet" Sept. 13, In Brief). The company also expects to accelerate its share repurchase program through 2000
Advertisement

Related Content

Avon
Avon
Advertisement
UsernamePublicRestriction

Register

RS007197

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel